Results 241 to 250 of about 11,920,429 (358)

Serum Proteomic Profile Based on the TGF-β Pathway Stratifies Risk of Hepatocellular Carcinoma. [PDF]

Liver Int
Xiang X, Shetty K, Yu H, Mishra B, Wong LL, Zhou XJ, Satapathy SK, Crawford JM, Latham PS, Han SH, Mathew B, Dagher NN, Lau L, Cacaj F, Vegesna AK, Dasarathy S, He AR, Huang H, Amdur RL, Mishra L.   +19 more
europepmc   +1 more source

Two-Dimensional Electrophoresis of Serum Proteins [PDF]

, 1956
Oliver Smithies, M. D. Poulik
openalex   +1 more source

Association of high‐dose radioactive iodine therapy with PPM1D‐mutated clonal hematopoiesis in older individuals

Molecular Oncology, EarlyView.
In thyroid cancer patients, high‐dose (≥7.4 GBq) radioactive iodine therapy (RAIT) was associated with a higher prevalence of clonal hematopoiesis (variant allele frequency >2%) in individuals aged ≥50 years (OR = 2.44). In silico analyses showed that truncating PPM1D mutations conferred a selective advantage under these conditions.
Jaeryuk Kim, Sungwoo Bae, Jaeyong Choi, Sun‐Wha Im, Bukyoung Cha, Gyeongseo Jung, Sun Wook Cho, Eul‐Ju Seo, Young Ah Lee, Jin Chul Paeng, Young Joo Park, Jong‐Il Kim   +11 more
wiley   +1 more source

High Molecular Crowding in Repair Foci Surrounding DNA Breaks, Measured by Fluorescence Lifetime Imaging Microscopy. [PDF]

FASEB J
Levchenko SM, Dobrucki JW.
europepmc   +1 more source

The influence of energy intake on protein metabolism [PDF]

, 1953
Hamish N. Munro, D. J. Naismith
openalex   +1 more source

Chimeric diphtheria toxin–CCL8 cytotoxic peptide for breast cancer management

Molecular Oncology, EarlyView.
DTCCL8 is a recombinant fusion toxin that targets cancer cells expressing chemokine receptors. By combining diphtheria toxin with CCL8, DTCCL8 binds to multiple receptors on tumor cells and induces selective cytotoxicity. This strategy enables receptor‐mediated targeting of cancer and may support the development of chemokine‐guided therapeutics ...
Bernardo Chavez, Asieh Naderi, Kim‐Tuyen Huynh‐Dam, Vitali Sikirzhytski, Ioulia Chatzistamou, Hippokratis Kiaris   +5 more
wiley   +1 more source

The proteomic landscape of diffuse midline glioma highlights the therapeutic potential of non-histone protein methyltransferases. [PDF]

Neuro Oncol
Anguraj Vadivel AK, Pajovic S, Siddaway R, Zhu S, Sbergio SG, Matic O, Phillips L, Bu YJ, Nitz M, Hawkins C.   +9 more
europepmc   +1 more source

ITGAV and SMAD4 influence the progression and clinical outcome of pancreatic ductal adenocarcinoma

Molecular Oncology, EarlyView.
In SMAD4‐positive pancreatic ductal adenocarcinoma (PDAC), integrin subunit alpha V (ITGAV) activates latent TGF‐β, which binds to the TGF‐β receptor and phosphorylates SMAD2/3. The activated SMAD2/3 forms a complex with SMAD4, and together they translocate to the nucleus, modulating gene expression to promote proliferation, migration, and invasion. In
Daniel K. C. Lee, Keyue Chen, Ryan Loke, Xiang Li, David Liubart, Golam T. Saffi, Jonathan T. S. Chow, Ché M. P. Melo, Lydia To, Leonardo Salmena   +9 more
wiley   +1 more source

Algae-dominated metaproteomes uncover cellular adaptations to life on the Greenland Ice Sheet. [PDF]

NPJ Biofilms Microbiomes
Feord HK, Trautwein-Schult A, Keuschnig C, Ostrzinski A, Peter EK, Jaeger C, Lisec J, Mourot R, Peters RS, Çiftçi O, Tranter M, Anesio AM, Becher D, Benning LG.   +13 more
europepmc   +1 more source

SECOND REPORT ON BARLEY PROTEINS: COMPOSITION AND QUANTITATIVE ESTIMATION OF THE BARLEY PROTEINS.-II

, 1929
L. R. Bishop
openalex   +1 more source